Vascular calcification in patients with renal failure: culprit or innocent bystander?

Santo Dellegrottaglie1, Rajiv Saran, Sanjay Rajagopalan

  • 1Zena and Michael A. Wiener Cardiovascular Institute and Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, Mount Sinai Medical Center, One Gustave L. Levy Place, New York, NY 10029, USA.

Cardiology Clinics
|August 9, 2005
PubMed

Insights

Vascular calcification (VC) is common in chronic kidney disease (CKD) and dialysis patients, contributing to high cardiovascular mortality. Further research is needed to understand VC

Area of Science:

  • Nephrology
  • Cardiology
  • Vascular Biology

Background:

  • Cardiovascular event mortality is significantly higher in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) compared to the general population.
  • Vascular calcification (VC) is prevalent and rapidly progressive in CKD and dialysis patients, contributing to this increased mortality.
  • While calcium and phosphate are key players, the paracrine and molecular mechanisms driving VC in renal failure are still being elucidated.

Purpose of the Study:

  • To review the current understanding of vascular calcification (VC) pathogenesis in CKD.
  • To highlight evolving knowledge on molecular determinants and inhibitors of VC.
  • To discuss the clinical utility of noninvasive VC detection and its prognostic potential in renal failure patients.

Main Methods:

  • Review of existing literature on vascular calcification (VC) in chronic kidney disease (CKD).
  • Discussion of molecular pathways and signaling molecules involved in VC.
  • Evaluation of noninvasive imaging techniques for VC detection.

Main Results:

  • Vascular calcification (VC) is a dynamic process influenced by an imbalance between pro-calcifying and anti-calcifying factors.
  • Emerging molecules like osteoprotegerin, fetuin-A, and MPG are key in understanding VC.
  • Noninvasive imaging (EBCT, MDCT) allows for VC detection and quantification.

Conclusions:

  • Vascular calcification (VC) is a significant issue in CKD and ESRD, linked to high cardiovascular mortality.
  • Understanding the molecular determinants of VC is crucial for developing targeted therapies.
  • Prospective studies are needed to validate the prognostic value of VC in CKD and ESRD populations.

Related Concept Videos

Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...